Skip to main content

Table 3 HIV related clinical characteristics of the study participants by nutritional status (N = 350)

From: Nutritional status and the associated factors among people living with HIV: an evidence from cross-sectional survey in hospital based antiretroviral therapy site in Kathmandu, Nepal

VariableN (%)Nutritional statusp value
Underweight
N = 64
Normal
N = 149
Overweight/Obese
N = 137
 
ART regimen    0.17
 Non-zidovudine based regimen215 (61.4)39 (18.1)84 (39.1)92 (42.8) 
 Zidovudine based regimen135 (38.6)25 (18.5)65 (48.1)45 (33.3) 
ART duration Median (range)48 (6, 168)0.12
 ≥ 24 months234 (66.9)49 (20.9)100 (42.7)85 (36.3) 
 <  24 months116 (33.1)15 (12.9)49 (42.2)52 (44.8) 
Opportunistic infection    0.15
 No338 (96.6)61 (18.0)143 (42.3)134 (39.6) 
 HCV7 (2.0)0 (0.0)5 (71.4)2 (28.6) 
 Tuberculosis4 (1.1)2 (50.0)1 (25.0)1 (25.0) 
 Syphilis1 (0.3)1 (100.0)0 (0.0)0 (0.0) 
WHO stage    0.04
 Stage I153 (43.7)21 (13.7)64 (41.8)68 (44.4) 
 Stage II81 (23.1)25 (30.9)32 (39.5)24 (29.6) 
 Stage III80 (22.9)13 (16.3)36 (45.0)31 (38.8) 
 Stage IV36 (10.3)5 (13.9)17 (47.2)14 (38.9) 
CD4 count Median (range) 368.5 (13, 1713)382 (5, 1468)440 (21, 1695)0.69
 Less than 200 cells/mm351 (14.6)12 (23.5)20 (39.2)19 (37.3) 
 Between 200 to 500 cells/mm3176 (50.3)34 (19.3)75 (42.6)67 (38.1) 
 Greater than 500 cells/ mm3123 (35.1)18 (14.6)54 (43.9)51 (41.5) 
Hemoglobin level    0.02
 Non-anemic238 (68)38 (16.0)92 (38.7)108 (45.4) 
 Anemic112 (32)26 (23.2)57 (50.9)29 (25.9)